Domain Associates API Closes on $28M Round Supporting Development of Colorectal Test, Biomarker Discovery Efforts Premium Applied Proteomics said this week that it has closed a $28 million Series C financing round. GenomeWeb Feature: The Unsteady March of Cancer Protein Biomarkers into the Clinic Premium In March 2010, Austin, Texas-based diagnostics firm Vermillion launched sales of its OVA1 ovarian cancer test. Epic Sciences Raises $13M in Series B Round NEW YORK (GenomeWeb News) – Epic Sciences today announced it has completed its Series B financing round raising $13 million. Astute Medical Completes $40M Series C Funding Round Premium Protein biomarker diagnostics firm Astute Medical this week said it had completed a Series C financing round that raised $40.4 million. Applied Proteomics Snags $22.5M in Funding; Aims to Optimize Mass Spec-Based Biomarker Discovery Premium By Adam Bonislawski Feb 10, 2012 People in the News: New Board Member, CEO at Applied Proteomics Premium Mar 11, 2011 Astute Medical Raises $13M for Protein Biomarker Dx Development Premium Nov 12, 2009 Microchip Biotechnologies Reels in $18.1M in Financing Breaking News New Method Generates High-Resolution Transcriptome-Wide Spatial Gene Expression Maps GE Healthcare, University of Cambridge Team on AI-Based Precision Oncology Qiagen Sued for Allegedly Infringing Patent With Wi-Fi-Connected Instrument Oppenheimer, BTIG Initiate Coverage of MDxHealth at Outperform, Buy Top Five Articles on GenomeWeb Last Week: Invitae, Beckman Coulter, Ancient DNA, and More Radiomics, OncoDNA Partner to ID Lung Cancer Biomarkers The Scan Omicron's Emergence The World Health Organization has called Omicron a SARS-CoV-2 "variant of concern," the Los Angeles Times writes. Not as Much Merck's pill to treat COVID-19 reduces the risk of hospitalization and death among COVID-19 patients by less than previously reported, the New York Times says. Bats That Hang Together Discover magazine writes that researchers have found a social microbiome among vampire bats. PLOS Papers on CEWAS, Simian Varicella Virus Transcriptome, Dermatomyositis Markers In PLOS this week: multi-omic approach to home in on genetic risk variants, transcriptomic analysis of the simian varicella virus, and more.